Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

691
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
691

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Sensitive and Simple Method for Trace Analysis of Pesticide Residues in Plant Guttation Fluids.

Journal of agricultural and food chemistry·2026
Same author

Serum syndecan-1 correlates with coronary artery calcification severity and intradialytic hypotension in elderly hemodialysis patients.

Frontiers in cardiovascular medicine·2026
Same author

Chemokine CCL21 promotes the pathological progression of endometriosis by regulating inflammatory cytokine expression and activating the NF-κB signaling pathway.

International immunopharmacology·2026
Same author

MXene-Based Piezoelectric and Triboelectric Energy Harvesters for Personalized Monitoring and Therapeutics.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Evaluating patient-reported outcomes in randomized controlled trials of targeted therapy and/or immunotherapy for liver cancer: a scoping review.

Frontiers in oncology·2026
Same author

Tongue Image Analysis and Clinical Data Fusion: A Novel Approach for Non-invasive Diagnosis of Metabolic Dysfunction-associated Fatty Liver Disease.

Journal of clinical and translational hepatology·2026

Related Experiment Video

Updated: Dec 9, 2025

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.2K

Liquid biopsy technologies for hematological diseases.

Yatian Fu1, Yiyuan Zhang1, Bee Luan Khoo1

  • 1Department of Biomedical Engineering, City University of Hong Kong, Kowloon Tong, Hong Kong, China.

Medicinal Research Reviews
|September 15, 2020
PubMed
Summary

Liquid biopsies offer less invasive disease diagnosis using circulating biomarkers like cell-free DNA (cfDNA) and extracellular vesicles (EV). These advancements, including microfluidics and AI, promise improved diagnostics and precision disease management.

Keywords:
cardiovascular diseasesdisease monitoringliquid biopsymultiomicspatient stratification

More Related Videos

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.4K
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
07:42

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

9.1K

Related Experiment Videos

Last Updated: Dec 9, 2025

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.2K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.4K
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
07:42

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

9.1K

Area of Science:

  • Biomarker Discovery
  • Translational Medicine
  • Diagnostic Technologies

Background:

  • The discovery of circulating tumor cells has paved the way for less invasive cancer diagnosis through blood-based biomarkers.
  • Liquid biopsy markers, including exfoliated cells, cfDNA, and EVs, offer a more convenient alternative to traditional biopsies.
  • Technological advancements enable the characterization of various diseases beyond cancer using these circulating biomarkers.

Purpose of the Study:

  • To review key cell-based, gene-based, and protein-based liquid biopsy markers (cfDNA, EV) for disease detection.
  • To discuss research progress in applying liquid biopsy biomarkers across different diseases.
  • To explore the role of microfluidics and AI in advancing point-of-care liquid biopsy applications.

Main Methods:

  • Review of existing literature on liquid biopsy technologies and applications.
  • Highlighting key technologies adopted for hematological diseases.
  • Introducing recent technological developments for cardiovascular disease, leukemia, and coronavirus disease detection.

Main Results:

  • Established technologies for hematological disease detection using liquid biopsies.
  • Emerging technologies for specific detection of cardiovascular, leukemia, and coronavirus diseases.
  • Identification of microfluidic technology and AI as crucial for point-of-care diagnostics.

Conclusions:

  • Liquid biopsy markers show significant potential for influencing disease management and treatment.
  • Noninvasive diagnostic capabilities of these technologies can advance precision disease management.
  • Integration of microfluidics and AI can enhance the development of point-of-care liquid biopsy applications.